Loading...
Sign in to edit your profile (add interests, mentoring, photo, etc.)

    Pam Taub

    Address9500 Gilman Drive #0902
    CA La Jolla 92093
    Phone760-634-8273
    vCardDownload vCard

      Collapse Overview 
      Collapse Overview
      Dr. Taub is a general cardiologist and assistant professor of medicine at the UC San Diego Health System. She is the director of the Hannah and Gene Step Cardiac Wellness and Rehabilitation Center that will be located in the new UC San Diego Jacobs Medical Center opening in 2016.

      The mission of the Center is to actively engage patients and the community in prevention of cardiovascular disease. In addition to having a comprehensive cardiac rehabilitation program for patients with established cardiac disease, the Center will provide evidence-based therapies and classes that will focus on disease prevention. The Center will be conducting research on biomarkers and other diagnostics, wearable/mobile technologies and various therapies that can improve patient outcomes.

      Dr. Taub's clinical practice focuses on preventive cardiology. She believes prevention is the “new frontier” in cardiovascular medicine. She takes an evidence-based approach to care that is tailored to the individual patient, with the goal of minimizing medications and procedures. She also actively collaborates with other specialists in providing cardiac care for the complex patient with multi-system disease.

      She is active in clinical/translational research and has received funding from the National Institutes of Health, American College of Cardiology and American Heart Association.


      Collapse ORNG Applications 
      Collapse Featured Publications
      Collapse Faculty Mentoring

      Collapse Bibliographic 
      Collapse Publications
      Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
      List All   |   Timeline
      1. Formentini L, Ryan AJ, Gálvez-Santisteban M, Carter L, Taub P, Lapek JD, Gonzalez DJ, Villarreal F, Ciaraldi TP, Cuezva JM, Henry RR. Mitochondrial H+-ATP synthase in human skeletal muscle: contribution to dyslipidaemia and insulin resistance. Diabetologia. 2017 Aug 02. PMID: 28770317.
        View in: PubMed
      2. Maisel AS, Wettersten N, van Veldhuisen DJ, Mueller C, Filippatos G, Nowak R, Hogan C, Kontos MC, Cannon CM, Müller GA, Birkhahn R, Clopton P, Taub P, Vilke GM, McDonald K, Mahon N, Nuñez J, Briguori C, Passino C, Murray PT. Neutrophil Gelatinase-Associated Lipocalin for Acute Kidney Injury During Acute Heart Failure Hospitalizations: The AKINESIS Study. J Am Coll Cardiol. 2016 Sep 27; 68(13):1420-31. PMID: 27659464.
        View in: PubMed
      3. Gutiérrez-Salmeán G, Meaney E, Lanaspa MA, Cicerchi C, Johnson RJ, Dugar S, Taub P, Ramírez-Sánchez I, Villarreal F, Schreiner G, Ceballos G. A randomized, placebo-controlled, double-blind study on the effects of (-)-epicatechin on the triglyceride/HDLc ratio and cardiometabolic profile of subjects with hypertriglyceridemia: Unique in vitro effects. Int J Cardiol. 2016 Nov 15; 223:500-506. PMID: 27552564.
        View in: PubMed
      4. Taub P, Ramirez-Sanchez I, Patel M, Higginbotham E, Moreno-Ulloa A, Román-Pintos LM, Phillips P, Perkins G, Ceballos G, Villarreal F. Beneficial effects of dark chocolate on exercise capacity in sedentary subjects: underlying mechanisms. A double blind, randomized, placebo controlled trial. Food Funct. 2016 Sep 14; 7(9):3686-93. PMID: 27491778; NIHMSID: NIHMS808667 [Available on 09/14/17].
        View in: PubMed
      5. Higginbotham E, Taub P. Cardiovascular Benefits of Dark Chocolate? Curr Treat Options Cardiovasc Med. 2015 Dec; 17(12):54. PMID: 26456559.
        View in: PubMed
      6. Maisel AS, Shah KS, Barnard D, Jaski B, Frivold G, Marais J, Azer M, Miyamoto MI, Lombardo D, Kelsay D, Iqbal N, Taub P, Kupfer K, Lee E, Clopton P, Zile M, Greenberg B. How B-Type Natriuretic Peptide (BNP) and Body Weight Changes Vary in Heart Failure With Preserved Ejection Fraction Compared With Reduced Ejection Fraction: Secondary Results of the HABIT (HF Assessment With BNP in the Home) Trial. J Card Fail. 2016 Apr; 22(4):283-93. PMID: 26433086.
        View in: PubMed
      7. Barnett CF, Moreno-Ulloa A, Shiva S, Ramirez-Sanchez I, Taub P, Su Y, Ceballos G, Dugar S, Schreiner G, Villarreal F. Pharmacokinetic, partial pharmacodynamic and initial safety analysis of (-)-epicatechin in healthy volunteers. Food Funct. 2015 Mar 11; 6(3):824-33. PMID: 25598082.
        View in: PubMed
      8. Shah KS, Taub P, Patel M, Rehfeldt M, Struck J, Clopton P, Mehta RL, Maisel AS. Proenkephalin predicts acute kidney injury in cardiac surgery patients. Clin Nephrol. 2015 Jan; 83(1):29-35. PMID: 25512100.
        View in: PubMed
      9. Ortiz-Vilchis P, Yamazaki KG, Rubio-Gayosso I, Ramirez-Sanchez I, Calzada C, Romero-Perez D, Ortiz A, Meaney E, Taub P, Villarreal F, Ceballos G. Co-administration of the flavanol (-)-epicatechin with doxycycline synergistically reduces infarct size in a model of ischemia reperfusion injury by inhibition of mitochondrial swelling. Eur J Pharmacol. 2014 Dec 5; 744:76-82. PMID: 25281837.
        View in: PubMed
      10. Tokman S, Barnett CF, Jarlsberg LG, Taub P, den Boon S, Davis JL, Cattamanchi A, Worodria W, Maisel A, Huang L. Procalcitonin predicts mortality in HIV-infected Ugandan adults with lower respiratory tract infections. Respirology. 2014 Apr; 19(3):382-8. PMID: 24460728.
        View in: PubMed
      11. Gutierrez-Salmean G, Ciaraldi TP, Nogueira L, Barboza J, Taub P, Hogan MC, Henry RR, Meaney E, Villarreal F, Ceballos G, Ramirez-Sanchez I. Effects of (-)-epicatechin on molecular modulators of skeletal muscle growth and differentiation. J Nutr Biochem. 2014 Jan; 25(1):91-4. PMID: 24314870.
        View in: PubMed
      12. Taub P, Ramirez-Sanchez I, Ciaraldi TP, Gonzalez-Basurto S, Coral-Vazquez R, Perkins G, Hogan M, Maisel AS, Henry RR, Ceballos G, Villarreal F. Perturbations in skeletal muscle sarcomere structure in patients with heart failure and type 2 diabetes: restorative effects of (-)-epicatechin-rich cocoa. Clin Sci (Lond). 2013 Oct; 125(8):383-9. PMID: 23642227.
        View in: PubMed
      13. Xue Y, Taub P, Iqbal N, Fard A, Clopton P, Maisel A. Mid-region pro-adrenomedullin adds predictive value to clinical predictors and Framingham risk score for long-term mortality in stable outpatients with heart failure. Eur J Heart Fail. 2013 Dec; 15(12):1343-9. PMID: 23887059.
        View in: PubMed
      14. Maisel A, Barnard D, Jaski B, Frivold G, Marais J, Azer M, Miyamoto MI, Lombardo D, Kelsay D, Borden K, Iqbal N, Taub P, Kupfer K, Clopton P, Greenberg B. Primary results of the HABIT Trial (heart failure assessment with BNP in the home). J Am Coll Cardiol. 2013 Apr 23; 61(16):1726-35. PMID: 23500322.
        View in: PubMed
      15. Taub P, Higginbotham E, Henry RR. Beneficial and detrimental effects of glycemic control on cardiovascular disease in type 2 diabetes. Curr Cardiol Rep. 2013 Feb; 15(2):332. PMID: 23314689.
        View in: PubMed
      16. Wentworth BA, Stein MB, Redwine LS, Xue Y, Taub P, Clopton P, Nayak KR, Maisel AS. Post-traumatic stress disorder: a fast track to premature cardiovascular disease? Cardiol Rev. 2013 Jan-Feb; 21(1):16-22. PMID: 22717656.
        View in: PubMed
      17. Prasain JK, Arabshahi A, Taub P, Sweeney S, Moore R, Sharer JD, Barnes S. Simultaneous quantification of F2-isoprostanes and prostaglandins in human urine by liquid chromatography tandem-mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci. 2013 Jan 15; 913-914:161-8. PMID: 23314354.
        View in: PubMed
      18. Ramirez-Sanchez I, Nogueira L, Moreno A, Murphy A, Taub P, Perkins G, Ceballos GM, Hogan M, Malek M, Villarreal F. Stimulatory effects of the flavanol (-)-epicatechin on cardiac angiogenesis: additive effects with exercise. J Cardiovasc Pharmacol. 2012 Nov; 60(5):429-38. PMID: 22833114.
        View in: PubMed
      19. Taub P, Borden KC, Fard A, Maisel A. Role of biomarkers in the diagnosis and prognosis of acute kidney injury in patients with cardiorenal syndrome. Expert Rev Cardiovasc Ther. 2012 May; 10(5):657-67. PMID: 22651841.
        View in: PubMed
      20. Xue Y, Taub P, Iqbal N, Fard A, Wentworth B, Redwine L, Clopton P, Stein M, Maisel A. Cardiac biomarkers, mortality, and post-traumatic stress disorder in military veterans. Am J Cardiol. 2012 Apr 15; 109(8):1215-8. PMID: 22305506.
        View in: PubMed
      21. Taub P, Fields JD, Wu AH, Miss JC, Lawton MT, Smith WS, Young WL, Zaroff JG, Ko NU. Elevated BNP is associated with vasospasm-independent cerebral infarction following aneurysmal subarachnoid hemorrhage. Neurocrit Care. 2011 Aug; 15(1):13-8. PMID: 21479679.
        View in: PubMed
      22. Nogueira L, Ramirez-Sanchez I, Perkins GA, Murphy A, Taub P, Ceballos G, Villarreal FJ, Hogan MC, Malek MH. (-)-Epicatechin enhances fatigue resistance and oxidative capacity in mouse muscle. J Physiol. 2011 Sep 15; 589(Pt 18):4615-31. PMID: 21788351.
        View in: PubMed
      23. Xue Y, Taub P, Fard A, Maisel AS. Hypervolemic and optivolemic natriuretic peptides in acute heart failure. Contrib Nephrol. 2011; 171:74-9. PMID: 21625093.
        View in: PubMed
      24. Taub P, Gabbai-Saldate P, Maisel A. Biomarkers of heart failure. Congest Heart Fail. 2010 Jul; 16 Suppl 1:S19-24. PMID: 20653707.
        View in: PubMed
      25. Yamazaki KG, Taub P, Barraza-Hidalgo M, Rivas MM, Zambon AC, Ceballos G, Villarreal FJ. Effects of (-)-epicatechin on myocardial infarct size and left ventricular remodeling after permanent coronary occlusion. J Am Coll Cardiol. 2010 Jun 22; 55(25):2869-76. PMID: 20579545.
        View in: PubMed
      26. Taub P, Daniels LB, Maisel AS. Usefulness of B-type natriuretic peptide levels in predicting hemodynamic and clinical decompensation. Heart Fail Clin. 2009 Apr; 5(2):169-75. PMID: 19249686.
        View in: PubMed